Evidence map›Paper›PMID 28675922›Full record

ArticleStatistics in medicine2017

How to control for unmeasured confounding in an observational time-to-event study with exposure incidence information: the treatment choice Cox model.

James Troendle, Eric Leifer, Zhiwei Zhang, Song Yang, Heather Tewes

Abstract read
In one paragraph

Article in Statistics in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

James TroendleOffice of Biostatistics Research, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH/DHHS, Bld RLK2 Room 9196, Bethesda, 20892, MD, U.S.A.ORCID http://orcid.org/0000-0002-7903-1015
Eric LeiferOffice of Biostatistics Research, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH/DHHS, Bld RLK2 Room 9196, Bethesda, 20892, MD, U.S.A.
Zhiwei ZhangDepartment of Statistics, University of California Riverside, 1430 Olmsted Hall, 900 University Ave., Riverside, 92521, CA, U.S.A.ORCID http://orcid.org/0000-0002-3187-9180
Song YangOffice of Biostatistics Research, Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, NIH/DHHS, Bld RLK2 Room 9196, Bethesda, 20892, MD, U.S.A.
Heather TewesData Management and Biometrics, Celerion, 621 Rose Street, Lincoln, NE 68502, U.S.A.
National Heart Lung and Blood Institute · USCelerion (United States) · USUniversity of California, Riverside · US

Funding

Intramural NIH HHS Z99 HL999999
6 · The paper itself

Abstract

In an observational study of the effect of a treatment on a time-to-event outcome, a major problem is accounting for confounding because of unknown or unmeasured factors. We propose including covariates in a Cox model that can partially account for an unknown time-independent frailty that is related to starting or stopping treatment as well as the outcome of interest. These covariates capture the times at which treatment is started or stopped and so are called treatment choice (TC) covariates. Three such models are developed: first, an interval TC model that assumes a very general form for the respective hazard functions of starting treatment, stopping treatment, and the outcome of interest and second, a parametric TC model that assumes that the log hazard functions for starting treatment, stopping treatment, and the outcome event include frailty as an additive term. Finally, a hybrid TC model that combines attributes from the parametric and interval TC models. As compared with an ordinary Cox model, the TC models are shown to substantially reduce the bias of the estimated hazard ratio for treatment when data are simulated from a realistic Cox model with residual confounding due to the unobserved frailty. The simulations also indicate that the bias decreases or levels off as the sample size increases. A TC model is illustrated by analyzing the Women's Health Initiative Observational Study of hormone replacement for post-menopausal women. Published 2017. This article has been contributed to by US Government employees and their work is in the public domain in the USA.

Indexed as

Confounding Factors, EpidemiologicProportional Hazards ModelsTreatment OutcomeBiasComputer SimulationFemaleHormone Replacement TherapyHumansIncidenceObservational Studies as TopicPostmenopausebiasfrailtyhazardmatchingpropensity

Identifiers

PMID28675922
PMCPMC5585047
OpenAlexW2732902028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.